COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 2665: Articles 26641-26650  | Next

What Can We Learn from the Time Evolution of COVID-19 Epidemic in Slovenia?
Baldea, I.
10.1101/2020.05.25.20112938 — Posted: 2020-05-26
Evaluation of the disinfecting capacity of ozone in emergency vehicles.
Biurrun, J., Garcia, B., Perez, A., Kochan, G., Escors, D., Crespo, J., Lasa, I., Echarri, A.
10.1101/2020.05.24.20111666 — Posted: 2020-05-26
SARS-CoV-2 detection in nasopharyngeal throat swabs by metagenomics
Tan, L. V., Hong, N. T. T., Ngoc, N. M., Thanh, T. T., Lam, V. T., Nguyet, L. A., Nhuc, L. N. T., Ny, N. T. H., Minh, N. N. Q., Man, D. N. H., Hang, V. T. T., Khanh, P. N. Q., Xuan, T. C., Phong, N. T., Tu, T. N. H., Hien, T. T., Hung, L. M., Truong, N. T., Yen, L. M., Dung, N. T., Thwaites, G., Nguyen, C.
10.1101/2020.05.24.20110205 — Posted: 2020-05-26
Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London
Zhou, J., Otter, J., Price, J. R., Cimpeanu, C., Meno Garcia, D., Kinross, J., Boshier, P., Mason, S., Bolt, F., Holmes, A. H., Barklay, W.
10.1101/2020.05.24.20110346 — Posted: 2020-05-26 Discussion: Onsite
IMPACT OF GLUCOCORTICOID TREATMENT IN SARS-COV-2 INFECTION MORTALITY: A RETROSPECTIVE CONTROLLED COHORT STUDY
Fernandez-Cruz, A., Ruiz-Antoran, B., Munoz-Gomez, A., Sancho-Lopez, A., Mills-Sanchez, P., Centeno-Soto, G. A., Blanco-Alonso, S., Javaloyes-Garachana, L., Galan-Gomez, A., Valencia-Alijo, A., Gomez-Irusta, J., Payares-Herrera, C., Morras-Torre, I., Sanchez-Chica, E., Delgado-Tellez-de-Cepeda, L., Callejas-Diaz, A., Ramos-Martinez, A., Munez-Rubio, E., Avendano-Sola, C.
10.1101/2020.05.22.20110544 — Posted: 2020-05-26
In Vitro Efficacy of Povidone-Iodine Nasal And Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)
Pelletier, J., Tessema, B., Westover, J., Frank, S., Brown, S., Capriotti, J.
10.1101/2020.05.25.20110239 — Posted: 2020-05-26 Discussion: Onsite
Effect of various treatment modalities on the novel coronavirus (nCOV-2019) infection in humans: a systematic review & meta-analysis
Misra, S., Nath, M., Hadda, V., Vibha, D.
10.1101/2020.05.24.20111799 — Posted: 2020-05-26
Prevalence and risk factors for mortality related to COVID-19 in a severely affected area of Madrid, Spain
Perez Tanoira, R., Perez Garcia, F., Romanyk, J., Gomez-Herruz, P., Arroyo, T., Gonzalez, R., Lledo Garcia, L., Verdu Exposito, C., Sanz Moreno, J., Gutierrez, I., Uribe Mathews, A., Lopez Ramos, E., Maceda Garcia, L., Troncoso, D., Cuadros, J.
10.1101/2020.05.25.20112912 — Posted: 2020-05-26
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva
Randad, P. R., Pisanic, N., Kruczynski, K., Manabe, Y. C., Thomas, D., Pekosz, A., Klein, S., Betenbaugh, M. J., Clarke, W. A., Laeyendecker, O., Caturegli, P. P., Larman, H. B., Detrick, B., Fairley, J. K., Sherman, A. C., Rouphael, N., Edupuganti, S., Granger, D. A., Granger, S. W., Collins, M., Heaney, C. D.
10.1101/2020.05.24.20112300 — Posted: 2020-05-26
Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network.
Casas Rojo, J. M., Anton Santos, J. M., Millan Nunez-Cortes, J., Lumbreras Bermejo, C., Ramos Rincon, J. M., Roy-Vallejo, E., Artero Mora, A., Arnalich Fernandez, F., Garcia Brunen, J. M., Vargas Nunez, J. A., Freire Castro, S. J., Manzano, L., Perales Fraile, I., Crestelo Vieitez, A., Puchades, F., Rodilla, E., Solis Marquinez, M. N., Bonet Tur, D., Fidalgo Moreno, M. d. P., Fonseca Aizpuru, E. M., Carrasco Sanchez, F. J., Rabadan Pejenaute, E., Rubio-Rivas, M., Torres Pena, J. D., Gomez Huelgas, R.
10.1101/2020.05.24.20111971 — Posted: 2020-05-26 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).